SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in PRLD — Prelude Therapeutics Inc
CIK 1446194
BALA CYNWYD, PA
Position in PRLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$915,834
+$521,698 QoQ
Shares Held
267,788
+97.0% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Derivatives in PRLD
reported options exposure · as of Mar 31, 2026CallValue
$71,820
CallShares
21,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. PRLD ranks #179 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in PRLD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,820 | 21,000 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $915,834 | 267,788 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $394,136 | 135,909 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $94,250 | 32,500 | Put | Other | 2026-02-17 | |
| 2025-06-30 | $32,341 | 39,977 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $59,804 | 77,870 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $92,818 | 72,799 | Shares | Other | 2025-02-14 | |
| 2023-03-31 | $739,176 | 129,680 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $563,471 | 93,290 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $535,410 | 81,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $89,836 | 13,591 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $153,614 | 29,428 | Shares | Defined | 2022-08-15 | |
| 2022-06-30 | $555,930 | 106,500 | Call | Defined | 2022-08-15 | |
| 2022-03-31 | $276,000 | 40,000 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $364,473 | 29,275 | Shares | Defined | 2022-04-05 | |
| 2021-09-30 | $613,437 | 19,630 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $491,090 | 17,153 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||